Musaffa Logo
Cellebrite DI Ltd CLBT
$11.05 $0.26 (2.30%) 1D

Last Updated: Aug 21, 12:00 AM·NASDAQ

Pricing for US stocks is delayed by 24 hours

CLBT Shariah Compliance

Screening Methodology: AAOIFI

As of August 2026, Cellebrite DI Ltd is classified as halal.

HALAL

Report Source: undefined Quarter Report

Cellebrite DI Ltd

Cellebrite DI Ltd. Stock Analysis CLBT

United States Information Technology Mid Cap

Cellebrite DI Ltd (CLBT) Chart

Financial Metrics & Statements of Cellebrite DI Ltd (CLBT)

FAQ's for Cellebrite DI Ltd (CLBT)

  • As of August 2026, Cellebrite DI Ltd CLBT is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
  • A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cellebrite DI Ltd using these criteria to determine its compliance status.
  • Muslim investors may consider investing in Cellebrite DI Ltd if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
  • Musaffa determines the Shariah status of Cellebrite DI Ltd by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
  • The Shariah compliance status of Cellebrite DI Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.
  • Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
  • You can check the latest Shariah compliance status of Cellebrite DI Ltd on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.